04.10.2016
At a conference on communication in the pharmaceutical industry, delegates discussed issues relevant to the pharmaceutical industry and emphasized the importance of open conversation and ongoing dialogue between the media and market experts.
More
Topics Petrovax Pharm
18.07.2016
NPO Petrovax Pharm passed an audit by the State Institute of Pharmaceuticals Quality Control of Slovakia, and was once again awarded the EU GMP production and quality management compliance certificate.
More
Topics Petrovax Pharm
22.03.2016
Petrovax Pharm is launching production of a state-of-the-art flu vaccine using virus antigens produced in Russia. The Ministry of Health of the Russian Federation has given the green light to start production.
More
Topics Petrovax Pharm
19.02.2016
NPO Petrovax Pharm concluded a trilateral agreement regarding strategic cooperation to localize the production of the Russian flu vaccine Grippol Plus in Iran.
More
Topics Petrovax Pharm
10.12.2015
NPO Petrovax Pharm received a Russian Nanotechnology Product label, confirming Grippol Plus flu vaccine’s quality, effectiveness and safety. The label is given to companies that manufacture products with the use of Russian nanotechnology and that meet high quality, safety and environmental requirements
More
Topics Petrovax Pharm